Concepedia

Andrew Haller

AH

5

Publications

211

Citations

5

H-Index

2006

Active since

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Roswell Park Comprehensive Cancer Center

Andrew Haller is an author at The Barbara Ann Karmanos Cancer Institute specializing in tumor biology, cancer research, and gene expression.

Top concepts

Publications per year

2006–2018

5

Publications

5

Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Qiuying Cheng, Xiang Ling, Andrew Haller et al. · PubMed · 2012 · 93 citations · Full text

, , +18

5,10‐methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children

Patricia Alcasabas, Yaddanapudi Ravindranath, Gerard Goyette et al. · Pediatric Blood & Cancer · 2008 · 49 citations

Transcriptional profiling of degraded RNA in cryopreserved and fixed tissue samples obtained at autopsy

Andrew Haller, Deepa Kanakapalli, Rosemarie Walter et al. · BMC Clinical Pathology · 2006 · 28 citations · Full text

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer

Jennifer Haynes, Trevor D. McKee, Andrew Haller et al. · Clinical Cancer Research · 2018 · 23 citations

High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy

Andrew Haller, Wei Phin Tan, Rochelle Payne Ondracek et al. · The Prostate · 2013 · 18 citations · Full text

Rows per page

1–5 of 5